Edesa Biotech Stock Price Prediction
| EDSA Stock | USD 2.44 0.06 2.40% |
Momentum 57
Buy Extended
Oversold | Overbought |
Using Edesa Biotech hype-based prediction, you can estimate the value of Edesa Biotech from the perspective of Edesa Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Edesa Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Edesa because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Edesa Biotech after-hype prediction price | USD 2.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Edesa |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edesa Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edesa Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Edesa Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Edesa Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Edesa Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Edesa Biotech Estimiated After-Hype Price Volatility
In the context of predicting Edesa Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Edesa Biotech's historical news coverage. Edesa Biotech's after-hype downside and upside margins for the prediction period are 0.13 and 13.64, respectively. We have considered Edesa Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Edesa Biotech is very risky at this time. Analysis and calculation of next after-hype price of Edesa Biotech is based on 3 months time horizon.
Edesa Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Edesa Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Edesa Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Edesa Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.86 | 11.08 | 0.00 | 0.05 | 0 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.44 | 2.63 | 4.37 |
|
Edesa Biotech Hype Timeline
Edesa Biotech is currently traded for 2.44. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.05. Edesa is projected to increase in value after the next headline, with the price projected to jump to 2.63 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 4.37%, whereas the daily expected return is currently at 0.86%. The volatility of related hype on Edesa Biotech is about 20066.14%, with the expected price after the next announcement by competition of 2.39. Edesa Biotech currently holds about 12.81 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83. Given the investment horizon of 90 days the next projected press release will be in a few days. Check out Edesa Biotech Basic Forecasting Models to cross-verify your projections.Edesa Biotech Related Hype Analysis
Having access to credible news sources related to Edesa Biotech's direct competition is more important than ever and may enhance your ability to predict Edesa Biotech's future price movements. Getting to know how Edesa Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Edesa Biotech may potentially react to the hype associated with one of its peers.
Edesa Biotech Additional Predictive Modules
Most predictive techniques to examine Edesa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Edesa using various technical indicators. When you analyze Edesa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Edesa Biotech Predictive Indicators
The successful prediction of Edesa Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Edesa Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Edesa Biotech based on analysis of Edesa Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Edesa Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Edesa Biotech's related companies.
Story Coverage note for Edesa Biotech
The number of cover stories for Edesa Biotech depends on current market conditions and Edesa Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Edesa Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Edesa Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Edesa Biotech Short Properties
Edesa Biotech's future price predictability will typically decrease when Edesa Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Edesa Biotech often depends not only on the future outlook of the potential Edesa Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Edesa Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.2 M | |
| Cash And Short Term Investments | 1 M |
Complementary Tools for Edesa Stock analysis
When running Edesa Biotech's price analysis, check to measure Edesa Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edesa Biotech is operating at the current time. Most of Edesa Biotech's value examination focuses on studying past and present price action to predict the probability of Edesa Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edesa Biotech's price. Additionally, you may evaluate how the addition of Edesa Biotech to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |